BioCentury
ARTICLE | Financial News

Tetraphase again amends IPO

March 20, 2013 12:28 AM UTC

Tetraphase Pharmaceuticals Inc. (Watertown, Mass.) amended its IPO and now plans to sell 8.3 million shares at $8-$10. A $9 price would raise about $75 million and value the company at $157.4 million. Barclays; BMO Capital Markets; Stifel; JMP Securities; and Needham are underwriters. Tetraphase proposed to raise up to $86.3 million in an IPO in February. Earlier this month, the company amended the IPO and said it planned to sell 6.8 million shares at $10-12 (see BioCentury Extra, March 6). ...